Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system

被引:135
作者
Gudmundsson, GH
Agerberth, B
机构
[1] Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
关键词
antibacterial peptides; innate immunity; microenvironment; evolutionary variation; bactericidal synergy;
D O I
10.1016/S0022-1759(99)00152-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The bactericidal machinery of mammalian neutrophils is built up of many components with different chemical properties, involving proteins, peptides and oxygen-dependent radicals. All these components work in synergy, leading to destruction and elimination of ingested microbes. During the eighties, it gradually became clear, that cationic peptides are a part of the oxygen-independent bactericidal effecters in phagocytic cells. In mammals, these antimicrobial peptides are represented by two families, the defensins and the cathelicidins. These potent broad spectra peptides are included as immediate effector molecules in innate immunity. The detailed killing mechanism for these effectors is partly known, but nearly all of them have membrane affinity, and permeate bacterial membranes, resulting in lysis of the bacteria. This peptide-membrane interaction includes also eukaryotic membranes, that implicates cytotoxic effects on host cells. Studies in vitro have established that the microenvironment is critical for their activities. In connection to cystic fibrosis, the effects of microenvironment changes are apparent, causing inactivation of peptide defences and leading to repeated serious bacterial infections. Thus, the importance of the microenvironment is also supported in vivo. Additional functions of these peptides such as chemotactic, mitogenic and stimulatory in the wound healing process suggest further important roles for these peptides. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 79 条
  • [1] Antibacterial components in bronchoalveolar lavage fluid from healthy in individuals and sarcoidosis patients
    Agerberth, B
    Grunewald, J
    Castaños-Velez, E
    Olsson, B
    Jörnvall, H
    Wigzell, H
    Eklund, A
    Gudmundsson, GH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) : 283 - 290
  • [2] FALL-39, A PUTATIVE HUMAN PEPTIDE ANTIBIOTIC, IS CYSTEINE-FREE AND EXPRESSED IN BONE-MARROW AND TESTIS
    AGERBERTH, B
    GUNNE, H
    ODEBERG, J
    KOGNER, P
    BOMAN, HG
    GUDMUNDSSON, GH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) : 195 - 199
  • [3] Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO
  • [4] 2-D
  • [5] The innate immune system in cystic fibrosis lung disease
    Bals, R
    Weiner, DJ
    Wilson, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) : 303 - 307
  • [6] The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
    Bals, R
    Wang, XR
    Zasloff, M
    Wilson, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9541 - 9546
  • [7] Befus AD, 1999, J IMMUNOL, V163, P947
  • [8] BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.iy.13.040195.000425
  • [9] MECHANISMS OF ACTION ON ESCHERICHIA-COLI OF CECROPIN-P1 AND PR-39, 2 ANTIBACTERIAL PEPTIDES FROM PIG INTESTINE
    BOMAN, HG
    AGERBERTH, B
    BOMAN, A
    [J]. INFECTION AND IMMUNITY, 1993, 61 (07) : 2978 - 2984
  • [10] SECONDARY STRUCTURE AND MEMBRANE INTERACTION OF PR-39, A PRO+ARG-RICH ANTIBACTERIAL PEPTIDE
    CABIAUX, V
    AGERBERTH, B
    JOHANSSON, J
    HOMBLE, F
    GOORMAGHTIGH, E
    RUYSSCHAERT, JM
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (03): : 1019 - 1027